vitamin q Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: COC1=C(OC)C(=O)C(=C(C)C1=O)C\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C
  • InChIKey: ACTIUHUUMQJHFO-UPTCCGCDSA-N
  • Mol. Mass: 863.36
  • ALogP: 17.85
  • ChEMBL Molecule:
    ubidecarenone  
More Chemistry

Pharmacology

Alternative names

2,3-dimethoxy-5-methyl-6-decaprenylbenzoquinone | api 31510 | armolipid | bio-quinone q10 | co-enzyme q10 | coenzyme q10 | coenzyme q-10 | coenzyme q10, ion (1-), (all-e)-isomer | coenzyme q10, (z,z,z,z,z,z,e,e,e)-isomer | coq10 | co-q-10 | coq 10 | neuquinon | q-ter | ubidecarenone | ubiquinone | ubiquinone 50 | ubiquinone q10 | ubisemiquinone | ubisemiquinone radical | uniquinon | vitamin q

Organizations (106)

Research & Development (106)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (60)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (60)


 

Absorption (Phase 1)

Alzheimer Disease (Phase 1)

Amyotrophic Lateral Sclerosis (Phase 2)

Astrocytoma (Phase 1)

Ataxia (Phase 1)

Bipolar Disorder (Phase 2)

Blood (Phase 1)

Breast Neoplasms (Phase 1)

Burns (Phase 1)

Carcinoma, Basal Cell (Phase 2)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Squamous Cell (Phase 2)

Cardiomyopathy, Dilated (Phase 4)

Cardiovascular Diseases (Phase 4)

Charcot-Marie-Tooth Disease (Phase 1/Phase 2)

Coronary Artery Disease (Phase 3)

Coronary Stenosis (Phase 3)

Death, Sudden, Cardiac (Phase 2)

Depression (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Diabetic Retinopathy (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Drugs, Investigational (Phase 4)

Dyslipidemias (Phase 3)

Fatigue Syndrome, Chronic (Phase 2/Phase 3)

Glaucoma, Open-Angle (Phase 1)

Glioblastoma (Phase 1)

Gliosarcoma (Phase 1)

Healthy Volunteers (Phase 4)

Heart Arrest (Phase 2)

Heart Failure (Phase 1)

Huntington Disease (Phase 3)

Hypertension (Phase 1)

Hypertension, Pulmonary (Phase 1)

Infertility (Phase 4)

Kidney Failure, Chronic (Phase 4)

Metabolic Syndrome (Phase 4)

Metabolism (Phase 4)

Mitochondrial Diseases (Phase 3)

Muscle Cramp (Phase 2/Phase 3)

Muscle Weakness (Phase 4)

Muscular Dystrophies, Limb-Girdle (Phase 2/Phase 3)

Muscular Dystrophy, Duchenne (Phase 3)

Myalgia (Phase 4)

Myelodysplastic Syndromes (Phase 2/Phase 3)

Neoplasms (Phase 1)

Nervous System Diseases (Phase 2/Phase 3)

Osteoporosis (Phase 2)

Pain (Phase 2/Phase 3)

Parkinson Disease (Phase 3)

Pre-Eclampsia (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Quality of Life (Phase 1/Phase 2)

Renal Dialysis (Phase 4)

Sleep Apnea Syndromes (Early Phase 1)

Spinal Cord Injuries (Phase 2)

Supranuclear Palsy, Progressive (Phase 2/Phase 3)

Vascular Calcification (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 91
  • # of Trial Organizations: 106

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue